In this dual podcast, we talk with leaders from the American Heart Association, Philips, UPMC, and Aphelion Capital about Cardeation Capital, a new venture fund aimed at funding start-ups in the digital health and medtech fields. How did the four entities join forces? What can they offer start-ups looking to disrupt healthcare? For more information go to aphelioncapital.net. You can also learn more about Aphelion Capital, the firm managing the fund, in this Medtech Talk Podcast.
American Heart Association
Nancy Brown has been Chief Executive Officer of the American Heart Association (AHA) since 2009. The Association is widely known and highly respected as the world’s largest voluntary health organization dedicated to preventing, treating and defeating cardiovascular diseases and stroke.
During her tenure as CEO, the AHA has become a global leader in the discovery and dissemination of heart disease and stroke science. Notably, under Nancy’s leadership the Association announced its bold new 2020 health impact goal: To improve the cardiovascular health of all Americans by 20 percent while reducing deaths from cardiovascular diseases and stroke by 20 percent. Nancy’s drive to set a brave long-term goal, at a time when many other organizations were focused on short-term needs, has provided a rallying point for the Association’s millions of volunteers, staff, and donors.
C. Talbot Heppenstall, Jr., has been treasurer at UPMC since 2003 and executive vice president since 2013. Mr. Heppenstall is responsible for overseeing the day-to-day cash needs of UPMC, along with the investment management of its $7.6 billion of cash and investments, its pension portfolio and oversight of its outstanding municipal bonds and other debt. As president of UPMC Enterprises, Mr. Heppenstall is leading UPMC’s efforts to commercialize its managerial and health care expertise, particularly in the area of information technology. With a focus first on improving the quality, efficiency and patient experience at UPMC, the division and its partners will then take those solutions to the broader health care market.
Previously, Mr. Heppenstall served as managing director at RBC Dain Rauscher Inc., president of PriMuni LLC, senior vice president at PNC Capital Markets and vice president at Butcher & Singer. He earned a bachelor’s degree from the University of Virginia and a master’s degree from Carnegie Mellon University.
Mr. Heppenstall currently serves on the boards of the St. Margaret Foundation, the Manchester Bidwell Development Trust, the Fox Chapel Golf Club and the Women’s Shelter of Greater Pittsburgh.
Connected Care and Health Informatics, Philips
Dr. Carla Kriwet is Executive Vice President and Chief Business Leader of Connected Care and Health Informatics, and a member of the Royal Philips Executive Committee. With more than 20 years of experience in medical devices and other technology companies, Carla has a successful record of achieving ambitious targets, delivering double-digit growth and leading organizations through transformations.
Ned has over 20 years of healthcare investing experience. Prior to forming Aphelion, Ned was a partner and managing director with Piper Jaffray Ventures where he focused on investments in emerging medical technology companies. Ned joined Piper from Janus Capital, where he was a senior research analyst covering both healthcare and internet investments. Before beginning his investment career Ned worked in sales and product management for two Fortune 500 firms.
Ned is a graduate of Colby College, Duke University's Fuqua School of Business, and was a post-graduate scholar at Oxford University. He has served on numerous private company boards over his career and enjoys working directly with entrepreneurs to help them build their companies in a capital efficient and less dilutive manner.
Meet Our Host
A follower and fan of medtech for nearly two decades, Tom Salemi is the former bureau chief, venture capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech.